Surgery Partners Statistics
Share Statistics
Surgery Partners has 127.11M shares outstanding. The number of shares has increased by 0.5% in one year.
| Shares Outstanding | 127.11M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 73.97M |
| Failed to Deliver (FTD) Shares | 737 |
| FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 10.16M, so 7.99% of the outstanding shares have been sold short.
| Short Interest | 10.16M |
| Short % of Shares Out | 7.99% |
| Short % of Float | 13.73% |
| Short Ratio (days to cover) | 17.29 |
Valuation Ratios
The PE ratio is -337.68 and the forward PE ratio is 22.98.
| PE Ratio | -337.68 |
| Forward PE | 22.98 |
| PS Ratio | 1.46 |
| Forward PS | 0.8 |
| PB Ratio | 2.02 |
| P/FCF Ratio | 19.6 |
| PEG Ratio | n/a |
Enterprise Valuation
Surgery Partners Inc. has an Enterprise Value (EV) of 6.88B.
| EV / Earnings | -578.49 |
| EV / Sales | 2.51 |
| EV / EBITDA | 14.32 |
| EV / EBIT | 20.99 |
| EV / FCF | 33.58 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.06.
| Current Ratio | 1.71 |
| Quick Ratio | 1.57 |
| Debt / Equity | 1.06 |
| Total Debt / Capitalization | 51.46 |
| Cash Flow / Debt | 0.14 |
| Interest Coverage | 1.7 |
Financial Efficiency
Return on equity (ROE) is -0.01% and return on capital (ROIC) is 5.09%.
| Return on Equity (ROE) | -0.01% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | 5.09% |
| Revenue Per Employee | 261.27K |
| Profits Per Employee | -1.13K |
| Employee Count | 10.50K |
| Asset Turnover | 0.4 |
| Inventory Turnover | 27.87 |
Taxes
| Income Tax | 300.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -37.26% in the last 52 weeks. The beta is 2.77, so Surgery Partners 's price volatility has been higher than the market average.
| Beta | 2.77 |
| 52-Week Price Change | -37.26% |
| 50-Day Moving Average | 27.3 |
| 200-Day Moving Average | 27.76 |
| Relative Strength Index (RSI) | 28.15 |
| Average Volume (20 Days) | 971.20K |
Income Statement
In the last 12 months, Surgery Partners had revenue of $2.74B and earned -$11.90M in profits. Earnings per share was $-0.09.
| Revenue | 2.74B |
| Gross Profit | 647.50M |
| Operating Income | 328.00M |
| Net Income | -11.90M |
| EBITDA | 480.80M |
| EBIT | 328.00M |
| Earnings Per Share (EPS) | -0.09 |
Balance Sheet
The company has $195.90M in cash and $3.06B in debt, giving a net cash position of -$2.87B.
| Cash & Cash Equivalents | 195.90M |
| Total Debt | 3.06B |
| Net Cash | -2.87B |
| Retained Earnings | -569.20M |
| Total Assets | 7.53B |
| Working Capital | 460.60M |
Cash Flow
In the last 12 months, operating cash flow was $293.80M and capital expenditures -$88.80M, giving a free cash flow of $205.00M.
| Operating Cash Flow | 293.80M |
| Capital Expenditures | -88.80M |
| Free Cash Flow | 205.00M |
| FCF Per Share | 1.63 |
Margins
Gross margin is 23.6%, with operating and profit margins of 11.96% and -0.43%.
| Gross Margin | 23.6% |
| Operating Margin | 11.96% |
| Pretax Margin | 4.92% |
| Profit Margin | -0.43% |
| EBITDA Margin | 17.53% |
| EBIT Margin | 11.96% |
| FCF Margin | 7.47% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.44% |
| FCF Yield | 7.92% |
Analyst Forecast
The average price target for SGRY is $35, which is 71.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $35 |
| Price Target Difference | 71.9% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Scores
| Altman Z-Score | 0.9 |
| Piotroski F-Score | 4 |